Use of growth hormone and growth hormone secretagogues in aging: Help or harm

Clinical Obstetrics and Gynecology

Volumn 44, Issue 4, 2001, Pages 893-901

  Khorram, Omid ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE DERIVATIVE; GROWTH HORMONE RELEASING FACTOR;

ARTHRALGIA; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; EDEMA; GERIATRIC DISORDER; HORMONAL THERAPY; HUMAN; IMMUNE SYSTEM; METABOLIC DISORDER; NERVE COMPRESSION; REVIEW; SIDE EFFECT; TREATMENT INDICATION;

AGING; BODY COMPOSITION; BONE AND BONES; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GROWTH HORMONE; HUMANS; IMMUNITY; LIPID METABOLISM; SAFETY; TIME FACTORS;

EID: 0035202408     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200112000-00026     Document Type: Review

References (45)

1. Thirty-second sampling of plasma growth hormone (GH) in man: Correlation with sleep stages
2. Human growth hormone and human aging
3. Consequences of growth hormone deficiency in adults and the benefits of recombinant human growth hormone treatment
4. Growth hormone secretion in the elderly: Ageing and the somatopause
5. Effects of human growth hormones in men over 60 years old
6. Effects of recombinant growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women
7. The effects of recombinant insulin-like growth factor-I and growth hormone on body composition in elderly women
8. One year of insulin-like growth factor 1 treatment does not affect bone density, body composition, or psychological measures in postmenopausal women
9. Growth hormone replacement in healthy older men improves body composition but not functional ability
10. Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency
11. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis as well as on body composition
12. Potent effects of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism
13. Effect of recombinant human growth hormone on the muscle strength response to resistance exercise in elderly men
14. Effect of growth hormone and resistance exercise on muscle growth and strength in older men
15. Growth hormone treatment of adults with growth hormone deficiency: Results of a 13-month placebo-controlled cross-over study
16. Growth hormone treatment in growth hormone-deficient adults: Effects on exercise performance
17. Three years of growth hormone treatment in growth hormone-deficient adults results in near normalization of body composition and physical performance
18. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults
19. The somatopause: Should growth hormone deficiency in older people be treated?
20. Human growth hormone and growth hormone releasing hormone: A double-masked, placebo-controlled study of their effects on bone metabolism in elderly women
21. Effect of recombinant human growth hormone in elderly osteoporotic women
22. Treatment of post-menopausal osteoporosis with a combination of growth hormone and pamidronate: A placebo -controlled trial
23. Treatment of osteoporosis with calcitonin, with and without growth hormone
24. Skeletal effects of cyclic recombinant growth hormone and salmon calcitonin in osteopenic postmenopausal women
25. Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency
26. Absence of growth hormone effects on cognitive function in girls with Turner's syndrome
27. Aging and immune function
28. The role of growth hormone in modulation of the immune response
29. Effects of long term, low-dose growth hormone therapy on immune function and life expectancy of mice
30. Effect of growth hormone and insulin-like growth factor I on the immune system
31. Exogenous growth hormone treatment alters body composition and increases natural killer cell activity in women with impaired endogenous growth hormone secretion
32. Effects of growth hormone and estrogen on T lymphocytes in older women
33. Acromegaly and gastrointestinal cancer
34. Acromegaly and multiple myeloma
35. Leukemia in growth hormone-treated patients: An update, 1992
36. Growth hormone and prostate cancer growth and metastasis in tumor-bearing animals
37. Growth hormone secretagogues: Clinical experience and therapeutic potential
38. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects
39. Stimulation of the growth (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretagogue (MK-677) in healthy elderly subjects
40. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women
41. Growth hormone (GH)-releasing hormone (1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men
42. 2 in age-advanced men and women
43. 2 administration on the immune system of aging men and women
44. Oral arginine does not stimulate basal or augment exercise-induced GH secretion in either young or old adults
45. Endocrine and lipid effects of oral L-arginine treatment in healthy postmenopausal women